Option Care Health Inc（OPCH）財務資料OPCHOption Care Health Inc

Option Care Health Inc (OPCH) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Infusion Services, accounting for 94.1% of total sales, equivalent to $246.98M. Another important revenue stream is PBM Services. Understanding this composition is critical for investors evaluating how OPCH navigates market cycles within the Healthcare Facilities & Services industry.

Evaluating the bottom line, Option Care Health Inc maintains a gross margin of 17.32%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 5.90%, while the net margin is 3.74%. These profitability ratios, combined with a Return on Equity (ROE) of 16.00%, provide a clear picture of how effectively OPCH converts its operational activities into shareholder value.

In the context of the broader market, OPCH competes directly with industry leaders such as LFST and CON. With a market capitalization of $4.68B, it holds a significant position in the sector. When comparing efficiency, OPCH's gross margin of 17.32% stands against LFST's 100.00% and CON's 28.41%. Such benchmarking helps identify whether Option Care Health Inc is trading at a premium or discount relative to its financial performance.

The company has shown consistent revenue growth, with total revenue increasing from approximately $1.34 billion in Q4 2024 to $1.46 billion in Q4 2025. The gross margin has remained stable around 18%, and the net income for Q2 2026 was approximately $53.9 million, reflecting solid profitability.